Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide. According to data from the World Health Organization, an estimated 19.8 million people die from CVDs each year, accounting for roughly 32% of all global deaths. Crucially, 85% of these fatalities are caused by ischaemic heart disease and cerebrovascular accidents. Over 75% of these deaths occur in low- and middle-income countries, where health infrastructure and early screening resources remain limited.
The underlying etiology of cardiovascular disease involves a complex interplay of behavioural, environmental, and physiological factors. Hypertension alone affects over 1.28 billion adults globally, serving as a primary silent catalyst for heart failure and myocardial infarction. Behavioural factors—such as physical inactivity, tobacco consumption, and diets high in refined sugars and sodium—drive systemic inflammation and metabolic syndrome. Research indicates that controlling systolic blood pressure and maintaining healthy lipid levels can diminish individual coronary risk by up to 50%.
Recognising the early symptoms of myocardial infarction is critical for clinical intervention:
-
Severe chest pressure, tightness, or squeezing sensations lasting more than a few minutes.
-
Pain radiating to the left shoulder, arms, neck, jaw, or back.
-
Shortness of breath, accompanied by cold sweats, dizziness, or lightheadedness.
Systemic prevention requires comprehensive public health strategies. Addressing risk factors at the community level—such as promoting nutritional literacy and implementing tobacco control legislation—substantially reduces disease incidence. To explore research and interventions in population health, visit Orapuh. Early detection via routine lipid panels, blood glucose monitoring, and clinical risk assessments ensures timely administration of essential pharmacotherapies, including antihypertensives, statins, and antiplatelet agents.